Newstral
Article
Financial Times on 2023-04-07 02:24
South Korean business & finance: South Korean biotech companies seek to diversify from China as US tensions rise
Related news
- South Korean business & finance: Global banks criticise South Korean short selling ban as ‘phantom farce’Financial Times
- South Korean business & finance: opinion content. Inside Business. Kepco debt crisis exposes South Korean vulnerabilitiesFinancial Times
- South Korean business & finance: South Korean film industry rocked by box office fraud allegationsFinancial Times
- South Korean business & finance: South Korea optimistic of inclusion in key world bond indexFinancial Times
- South Korean business & finance: South Korea launches samurai bond in Japan as bilateral relations improveFinancial Times
- Trump ups trade tensions with South Korean leaderstaradvertiser.com
- FSouth Korean biotech IPO fuels concerns of bubble in sectorft.com
- China envoy praises N. Korean for easing tensions with Southnwaonline.com
- South Korean president snubs Nancy Pelosi as China tensions riseFinancial Times
- Trump meets with South Korean president amid North Korea tensionskcci.com
- BSouth Korea Finance Chief Hopeful of Easing Tensions With Chinabloomberg.com
- Chinese business & finance: China’s drug-pricing policy impedes biotech profitsFinancial Times
- South Korean president says Olympics have lowered tensions with Northtelegram.com
- South Korean activist floats leaflets to North amid tensionsThe Fresno Bee
- South Korea’s unification minister resigns as Korean tensions riseNew York Post
- AThe tone of tensions: Korean voices, North and Southapnewsarchive.com